Armata Pharmaceuticals Secures $3.7 Million for Phase 3 Development of Antibiotic-Resistant Therapy #USA #Los_Angeles #Armata_Pharmaceuticals #AP-SA02 #antimicrobial_therapy

Armata Pharmaceuticals Secures $3.7 Million for Phase 3 Development of Antibiotic-Resistant Therapy #USA #Los_Angeles #Armata_Pharmaceuticals #AP-SA02 #antimicrobial_therapy